table of content
1 Introduction to Research & Analysis Reports
1.1 Endothelin Antagonist Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endothelin Antagonist Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endothelin Antagonist Therapy Overall Market Size
2.1 Global Endothelin Antagonist Therapy Market Size: 2023 VS 2030
2.2 Global Endothelin Antagonist Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Endothelin Antagonist Therapy Players in Global Market
3.2 Top Global Endothelin Antagonist Therapy Companies Ranked by Revenue
3.3 Global Endothelin Antagonist Therapy Revenue by Companies
3.4 Top 3 and Top 5 Endothelin Antagonist Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Endothelin Antagonist Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Endothelin Antagonist Therapy Players in Global Market
3.6.1 List of Global Tier 1 Endothelin Antagonist Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Endothelin Antagonist Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Endothelin Antagonist Therapy Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type - Global Endothelin Antagonist Therapy Revenue & Forecasts
4.2.1 By Type - Global Endothelin Antagonist Therapy Revenue, 2019-2024
4.2.2 By Type - Global Endothelin Antagonist Therapy Revenue, 2025-2030
4.2.3 By Type - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endothelin Antagonist Therapy Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Endothelin Antagonist Therapy Revenue & Forecasts
5.2.1 By Application - Global Endothelin Antagonist Therapy Revenue, 2019-2024
5.2.2 By Application - Global Endothelin Antagonist Therapy Revenue, 2025-2030
5.2.3 By Application - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Endothelin Antagonist Therapy Market Size, 2023 & 2030
6.2 By Region - Global Endothelin Antagonist Therapy Revenue & Forecasts
6.2.1 By Region - Global Endothelin Antagonist Therapy Revenue, 2019-2024
6.2.2 By Region - Global Endothelin Antagonist Therapy Revenue, 2025-2030
6.2.3 By Region - Global Endothelin Antagonist Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Endothelin Antagonist Therapy Revenue, 2019-2030
6.3.2 US Endothelin Antagonist Therapy Market Size, 2019-2030
6.3.3 Canada Endothelin Antagonist Therapy Market Size, 2019-2030
6.3.4 Mexico Endothelin Antagonist Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Endothelin Antagonist Therapy Revenue, 2019-2030
6.4.2 Germany Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.3 France Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.4 U.K. Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.5 Italy Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.6 Russia Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Endothelin Antagonist Therapy Market Size, 2019-2030
6.4.8 Benelux Endothelin Antagonist Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Endothelin Antagonist Therapy Revenue, 2019-2030
6.5.2 China Endothelin Antagonist Therapy Market Size, 2019-2030
6.5.3 Japan Endothelin Antagonist Therapy Market Size, 2019-2030
6.5.4 South Korea Endothelin Antagonist Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Endothelin Antagonist Therapy Market Size, 2019-2030
6.5.6 India Endothelin Antagonist Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Endothelin Antagonist Therapy Revenue, 2019-2030
6.6.2 Brazil Endothelin Antagonist Therapy Market Size, 2019-2030
6.6.3 Argentina Endothelin Antagonist Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Endothelin Antagonist Therapy Revenue, 2019-2030
6.7.2 Turkey Endothelin Antagonist Therapy Market Size, 2019-2030
6.7.3 Israel Endothelin Antagonist Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Endothelin Antagonist Therapy Market Size, 2019-2030
6.7.5 UAE Endothelin Antagonist Therapy Market Size, 2019-2030
7 Endothelin Antagonist Therapy Companies Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Endothelin Antagonist Therapy Major Product Offerings
7.1.4 Gilead Sciences Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 Sun Pharmaceutical Industries
7.2.1 Sun Pharmaceutical Industries Company Summary
7.2.2 Sun Pharmaceutical Industries Business Overview
7.2.3 Sun Pharmaceutical Industries Endothelin Antagonist Therapy Major Product Offerings
7.2.4 Sun Pharmaceutical Industries Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.2.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.3 Lupin
7.3.1 Lupin Company Summary
7.3.2 Lupin Business Overview
7.3.3 Lupin Endothelin Antagonist Therapy Major Product Offerings
7.3.4 Lupin Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.3.5 Lupin Key News & Latest Developments
7.4 Zydus Group
7.4.1 Zydus Group Company Summary
7.4.2 Zydus Group Business Overview
7.4.3 Zydus Group Endothelin Antagonist Therapy Major Product Offerings
7.4.4 Zydus Group Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.4.5 Zydus Group Key News & Latest Developments
7.5 Endo International
7.5.1 Endo International Company Summary
7.5.2 Endo International Business Overview
7.5.3 Endo International Endothelin Antagonist Therapy Major Product Offerings
7.5.4 Endo International Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.5.5 Endo International Key News & Latest Developments
7.6 Mylan N.V
7.6.1 Mylan N.V Company Summary
7.6.2 Mylan N.V Business Overview
7.6.3 Mylan N.V Endothelin Antagonist Therapy Major Product Offerings
7.6.4 Mylan N.V Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.6.5 Mylan N.V Key News & Latest Developments
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Company Summary
7.7.2 Teva Pharmaceutical Industries Business Overview
7.7.3 Teva Pharmaceutical Industries Endothelin Antagonist Therapy Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.7.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.8 Sigmapharm Laboratories
7.8.1 Sigmapharm Laboratories Company Summary
7.8.2 Sigmapharm Laboratories Business Overview
7.8.3 Sigmapharm Laboratories Endothelin Antagonist Therapy Major Product Offerings
7.8.4 Sigmapharm Laboratories Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.8.5 Sigmapharm Laboratories Key News & Latest Developments
7.9 Alembic Pharmaceuticals
7.9.1 Alembic Pharmaceuticals Company Summary
7.9.2 Alembic Pharmaceuticals Business Overview
7.9.3 Alembic Pharmaceuticals Endothelin Antagonist Therapy Major Product Offerings
7.9.4 Alembic Pharmaceuticals Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.9.5 Alembic Pharmaceuticals Key News & Latest Developments
7.10 Hikma Pharmaceuticals
7.10.1 Hikma Pharmaceuticals Company Summary
7.10.2 Hikma Pharmaceuticals Business Overview
7.10.3 Hikma Pharmaceuticals Endothelin Antagonist Therapy Major Product Offerings
7.10.4 Hikma Pharmaceuticals Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.10.5 Hikma Pharmaceuticals Key News & Latest Developments
7.11 Amneal Pharmaceuticals
7.11.1 Amneal Pharmaceuticals Company Summary
7.11.2 Amneal Pharmaceuticals Business Overview
7.11.3 Amneal Pharmaceuticals Endothelin Antagonist Therapy Major Product Offerings
7.11.4 Amneal Pharmaceuticals Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.11.5 Amneal Pharmaceuticals Key News & Latest Developments
7.12 AstraZeneca
7.12.1 AstraZeneca Company Summary
7.12.2 AstraZeneca Business Overview
7.12.3 AstraZeneca Endothelin Antagonist Therapy Major Product Offerings
7.12.4 AstraZeneca Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.12.5 AstraZeneca Key News & Latest Developments
7.13 Johnsons & Johnsons Private limited
7.13.1 Johnsons & Johnsons Private limited Company Summary
7.13.2 Johnsons & Johnsons Private limited Business Overview
7.13.3 Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Major Product Offerings
7.13.4 Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Revenue in Global Market (2019-2024)
7.13.5 Johnsons & Johnsons Private limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
